Company intelligence / Profile preview

CardioVia

Ownership: Private
Development stage: Commercial

Overview

CardioVia’s ViaOne system is a minimally invasive, FDA-cleared medical device designed to provide safe and controlled access to the heart’s outer surface for diagnostic and therapeutic procedures. Clinical evidence, including a study published in JACC Clinical Electrophysiology, demonstrates its safety and effectiveness in reducing complications such as heart perforation compared to traditional sharp needle techniques. The company is preparing for commercial launch at leading cardiac centers across the US.

Therapeutic areas: Cardiovascular
Modalities: DeviceMinimally invasive medical device system (ViaOne)
Industry: Surgical Medical Devices

Partnerships

Collaboration with Hadassah Medical Center, Jerusalem, Israel

Beyond the preview

Go deeper on CardioVia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CardioVia.

Explore the full profile